IDH1 and brain neoplasm: Indeed, entity-overlapping mutations were exclusively detectable in ARID1A and IDH2. In men, IDH2 mutations are linked to brain tumors and acute myeloid leukemia, while IDH1 mutations may drive tumor progression.